248f06x3 - ECONOMICS 248 FINAL EXAM FALL 2006 NAME: _ You...

Info iconThis preview shows pages 1–2. Sign up to view the full content.

View Full Document Right Arrow Icon
ECONOMICS 248 FINAL EXAM FALL 2006 NAME: ______________________ You may not take this exam off of the 2nd floor of Quigley Hall. If you do, you will automatically fail. The following story is excerpted from an article in The New York Times . The information is relevant to questions 1-6. More Deaths Are Linked to Device The New York Times December 14, 2005 By BARRY MEIER The Food and Drug Administration has received from the Guidant Corporation several new reports about recent patient deaths associated with short circuits in company heart devices, agency records show. The three new cases all occurred after June when Guidant recalled the heart devices at issue. The recalls took place after the company came under scrutiny for failing to promptly warn doctors and patients about the risks of short circuits. The new reports bring the number of known deaths associated with the flaw to seven. The new data may pose further legal problems for Guidant because the electrical failures, while involving different models, are all related to the company's use of an insulating material in a way that apparently made it prone to deterioration. The Justice Department, as part of an investigation into Guidant's handling of safety issues, is looking into its use of that material, called polyimide. In a statement, Guidant, which is based in Indianapolis, said that it "regularly communicates information about product performance to various stakeholders including physicians and regulatory bodies." The company also pointed out that it had recently begun publicly releasing more detailed data about product malfunctions. In 2002, Guidant discovered that one of its heart devices was prone to short-circuiting. Company officials declined to respond yesterday to written questions about the steps Guidant took, if any, at that time to determine if other company heart devices had the same flaw. Both the F.D.A. and Guidant have told patients with the affected units that they should consult with their doctors to decide whether the risks posed by the device outweighed those posed by replacement surgery. One heart device specialist, Dr. William H. Maisel, who is based in Boston, said yesterday that the new death reports should not necessarily affect those decisions, because most doctors look at a device's overall failure rate, rather than the percentage of those failures that involve deaths. The Guidant devices at issue include a defibrillator known as the Prizm 2 DR as well as a
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Image of page 2
This is the end of the preview. Sign up to access the rest of the document.

This test prep was uploaded on 04/22/2008 for the course ECON 248 taught by Professor Nonnenmacher during the Fall '08 term at Allegheny.

Page1 / 9

248f06x3 - ECONOMICS 248 FINAL EXAM FALL 2006 NAME: _ You...

This preview shows document pages 1 - 2. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online